Products for Research Use Only
RegisterLogin

BCN-DOTA

CAT: 0804-HY-164574-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-164574-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BCN-DOTA is a cyclooctyne-linked DOTA chelator that can be radiolabeled with zirconium-89 as a radionuclide-labeled drug conjugate (RDC) to target specific biomolecules, cells, or tissues.
CAS Number
2565792-45-0
UNSPSC
12352203
Target
Radionuclide-Drug Conjugates (RDCs)
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcn-dota.html
Smiles
O=C(NCCNC(OC[C@H]1[C@@]2([H])CCC#CCC[C@@]12[H])=O)CN3CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC3
Molecular Formula
C29H46N6O9
Molecular Weight
622.71
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
RDC Bifunctional Chelator

Related Products

CatalogName
HY-173390BCN-E-BCN
HY-163040DOTA-Tyr-Lys-DOTA
HY-P11254DOTA-FAPT
HY-163039DOTA-biotin
HY-139564DOTA Zoledronate
HY-W802013DOTA-4AMP
HY-W038001DOTA-benzene
HY-P5128-01DOTA-JR11
HY-133540-01Maleimide-DOTA
HY-W678394-01DOTA-Thiol

Alternative Products

CatalogName
MBS5779941BCN-E-BCN
GTR19267069-01DOTA-Tyr-Lys-DOTA
TRC-D535500-250MGDOTA
MD253253-2endo-BCN-PEG2-endo-BCN
BA5818-1DOTA-LM3
413907Gd-DOTA
4029066.0250DOTA (OtBu) ₃
4029066.05DOTA(OtBu)₃
TSH-00037-01DOTA-amide
MBS3847771-01DOTA-JR11

Popular Products